Since JAK2 point mutations are associated with CRLF2 mRNA overexpression and treatment response in ALL patients [13], we sequenced the fragment of the JAK2 gene that encodes the kinase and pseudokinase domains and identified JAK2 mutations in 7 CRLF2pos samples. The gene discussed is CRLF2; the disease is acute lymphoblastic leukemia.